Select Page

Minneapolis Mayor Signs Order Deprioritizing Psychedelics Policing

Media Partners, Psychedelic News Wire

This post is presented by our media partner Psychedelic News Wire
View the original article here.

Drug reform activists in Minnesota scored a major win after Minneapolis Mayor Jacob Fred signed an order that requires the police department and related agencies to deprioritize the arrest, investigation and conviction of people for psychedelic-related charges. The executive order deprioritizes policing for certain psychedelics, stating that investigating and arresting Minneapolis residents for the cultivation, distribution, purchase or possession of entheogenic plants will be of the “lowest law enforcement priority.”

Psychoactive or entheogenic compounds refer to plants that naturally induce hallucinogenic experiences when ingested. They include mescaline, psilocybin (magic mushrooms), iboga and ayahuasca tea. However, Frey explained that these entheogenic plants such as magic mushrooms also exhibit benefits, especially for people with mental disorders, including post-traumatic stress disorder, anxiety, and severe depression.

Although most psychedelic-related research is still in its infancy, studies have found that various hallucinogenic compounds can deliver potent mental health benefits, granting patients long-term relief from severe mental health conditions with barely any side effects. Preliminary findings on the mental health benefits of psychedelics have been so encouraging that lawmakers in several states are already working to amend existing drug policies and legalize the therapeutic use of psychedelics.

In the meantime, investors and Big Pharma are pouring millions of dollars into furthering psychedelic research and funding the development of psychedelic-assisted therapies for conditions such as major depressive disorder and PTSD that often fail to respond to conventional treatments.

Frey said that he would not ignore the growing body of evidence pointing to psychedelics’ therapeutic potential. Furthermore, he said that he didn’t support the elimination of a tool that could help the country deal with its increasingly dire mental health crisis.

Noting that many Minneapolis residents use psychedelics for religious or health purposes, Frey directed the city’s police department to deprioritize law enforcement activities related to entheogens. However, Frey said that Minneapolis is only decriminalizing certain psychedelics, not legalizing recreational psychedelic use. The executive order also does not allow any “unlawful activities” associated with entheogens.

By deprioritizing the policing of psychedelic-related offenses, Frey said that the city would be able to direct resources to more crucial issues such as the fentanyl crisis and violent crime.

Law enforcement in Minnesota had already made psychedelics less of a priority prior to the Minneapolis executive order, with Minnesota Bureau of Criminal Apprehension data showing that police only made three psychedelic-related arrests in 2022. The executive order from Frey now codifies the decision to deprioritize psychedelic-related offenses into law.

As more entities such as Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) continue to engage in psychedelics research and publish their findings, many more jurisdictions are likely to tweak their drug laws to accommodate psychedelic substances that hold a lot promise for improving human health.

NOTE TO INVESTORS: The latest news and updates relating to Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) are available in the company’s newsroom at https://ibn.fm/DELCF

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

This post was originally published by our media partner here.